Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 236.71 | 226.10 | 187.95 | 158.57 | 168.25 |
| Expenses | |||||
| Material consumed | 93.18 | 95.96 | 80.80 | 56.23 | 72.93 |
| Manufacturing expenses | 0.29 | 0.47 | 0.52 | 0.64 | 1.41 |
| Personnel expenses | 56.42 | 57.68 | 53.98 | 50.37 | 46.61 |
| Selling expenses | 15.47 | 12.09 | 11.83 | 16.29 | - |
| Adminstrative expenses | 37.21 | 34.11 | 21.73 | 26.49 | 36.54 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 202.56 | 200.30 | 168.87 | 150.04 | 157.49 |
| Operating profit | 34.15 | 25.79 | 19.08 | 8.53 | 10.76 |
| Other recurring income | 5.73 | 3.34 | 4.39 | 2.53 | - |
| Adjusted PBDIT | 39.89 | 29.13 | 23.47 | 11.06 | - |
| Financial expenses | 0.41 | 0.29 | 1.09 | 0.51 | 0.75 |
| Depreciation | 1.21 | 1.53 | 0.51 | 1.13 | 1.02 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 38.27 | 27.32 | 21.87 | 9.41 | 9.00 |
| Tax charges | 8.09 | 7.73 | 4.81 | 1.54 | 1.79 |
| Adjusted PAT | 30.18 | 19.59 | 17.06 | 7.87 | 7.22 |
| Non recurring items | -5.01 | 1.36 | 0.15 | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 25.17 | 20.95 | 17.21 | 7.87 | 7.22 |
| Earnigs before appropriation | 94.54 | 79.53 | 64.90 | 49.00 | 41.92 |
| Equity dividend | - | 10.48 | 2.62 | 1.31 | 0.79 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 94.54 | 69.05 | 62.28 | 47.69 | 41.13 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis